Furthermore, our result is in accord with a study conducted by Pan and Quian, who used apocynin in a rat model of cerebral infarction and found that apocynin treatment significantly decreased NF-κB mRNA expression [47]. The gene discussed is NFKB1; the disease is cerebral infarction.